Glycosylphosphatidylinositol toxin of plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and e-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinasedependent signal transduction, J. Immunol, vol.5, pp.1886-1896, 1996. ,
Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria, Nature, vol.8, issue.6899, pp.785-789, 2002. ,
DOI : 10.1084/jem.192.11.1563
Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: Activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties, Proc. Nat. Acad. Sci. USA, pp.4022-4027, 1997. ,
DOI : 10.1073/pnas.94.8.4022
Structure and activity of glycosylphosphatidylinositol anchors of Plasmodium falciparum, Mic. Infect, vol.9, pp.983-990, 2002. ,
Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites, Journal of Experimental Medicine, vol.177, issue.1, pp.145-153, 1993. ,
DOI : 10.1084/jem.177.1.145
Glucosamine inhibits inositol acylation of the glycosylphosphatidylinositol anchors in intraerythrocytic Plasmodium falciparum, J. Biol ,
Innate immunity to malaria, Nature Reviews Immunology, vol.161, issue.3, pp.169-180, 2004. ,
DOI : 10.1038/nri1311
Signaling of immune system cells by glycosylphosphatidylinositol (GPI) anchor and related structures derived from parasitic protozoa, Current Opinion in Microbiology, vol.3, issue.4, pp.395-403, 2000. ,
DOI : 10.1016/S1369-5274(00)00111-9
Glycosylphosphatidylinositol anchors of Plasmodium falciparum: molecular characterization and naturally elicited antibody response that may provide immunity to malaria pathogenesis, J. Exp. Med, pp.11-1563, 2000. ,
Antibodies to Plasmodium falciparum glycosylphosphatidylinositols: inverse association with tolerance of parasitemia in Papua New Guinean children and adults, Infect. Immun, vol.9, pp.5052-5057, 2002. ,
Prevalence and Boosting of Antibodies to Plasmodium falciparum Glycosylphosphatidylinositols and Evaluation of Their Association with Protection from Mild and Severe Clinical Malaria, Infection and Immunity, vol.70, issue.9, pp.5045-5051, 2002. ,
DOI : 10.1128/IAI.70.9.5045-5051.2002
IgG) responses to Plasmodium falciparum glycosylphosphatidylinositols are short-lived and predominantly of the IgG3 subclass ,
Malaria in the central health district of Dakar (Senegal). Entomological, parasitological and clinical data, Cahier Sante, pp.221-229, 2000. ,
The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor, Journal of Experimental Medicine, vol.160, issue.2 ,
DOI : 10.1084/jem.160.2.624
Clinical immunity to Plasmodium falciparum malaria is associated with 15 ,
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity, Parasite Immunol, vol.3, pp.321-337, 1992. ,
Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria ,
The crystal structure of Cterminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate, Molec. Cell, vol.4, pp.457-464, 1999. ,
Distinct surrogate markers for protection against Plasmodium falciparum infection and clinical malaria identified in a Senegalese community after radical drug cure, J. Infect. Dis, pp.1940-1950, 2003. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00566835
Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein-1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village, J. Infect. Dis, 2004. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00494323
Vector density gradients and the epidemiology of urban malaria in Dakar ,
Combating malaria morbidity and mortality by reducing transmission, Parasitology Today, vol.12, issue.6, pp.236-240, 1996. ,
DOI : 10.1016/0169-4758(96)10015-6
URL : http://horizon.documentation.ird.fr/exl-doc/pleins_textes/pleins_textes_6/b_fdi_45-46/010007030.pdf
Crystal structure of a Fab complex formed with PfMSP1-19, the Cterminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate, J. Mol. Biol, vol.5, pp.1091-1103, 2003. ,
Evaluation of anti-Plasmodium falciparum antibodies in Senegalese adults using different types of crude extracts from various strains of parasite, Mic. Infect, vol.1, pp.31-35, 2002. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00566852
The malaria vaccine: anti-parasite or anti-disease?, Immunology Today, vol.11, pp.25-27, 1990. ,
DOI : 10.1016/0167-5699(90)90007-V
The prognostic and pathophysiologic role of pro-and antiinflammatory cytokines in severe malaria, J. Inf. Dis, vol.4, pp.1288-1297, 1999. ,